Results 111 to 120 of about 845 (125)
Some of the next articles are maybe not open access.
FASEB Journal, 2022
Abstract Erythroid differentiation (ED) is a complex cellular process entailing morphologically distinct maturation stages of erythroblasts during terminal differentiation. Studies of actin filament (F‐actin) assembly and organization during terminal ED have revealed essential roles for the F‐actin pointed‐end ...
Velia Fowler +2 more
exaly +3 more sources
Abstract Erythroid differentiation (ED) is a complex cellular process entailing morphologically distinct maturation stages of erythroblasts during terminal differentiation. Studies of actin filament (F‐actin) assembly and organization during terminal ED have revealed essential roles for the F‐actin pointed‐end ...
Velia Fowler +2 more
exaly +3 more sources
Drug Resistance Updates
The high prevalence of KRAS mutations in pancreatic cancer (PC) is widely acknowledged and results in the resistance of targeted ferroptosis therapy and immunotherapy. Herein, via a CRISPR/Cas9 library screen, the effects of ferroptosis agonists were increased in KRAS-mutant PC cells upon knockout of tropomodulin 3 (TMOD3), while these effects were not
Zhirui Zeng
exaly +3 more sources
The high prevalence of KRAS mutations in pancreatic cancer (PC) is widely acknowledged and results in the resistance of targeted ferroptosis therapy and immunotherapy. Herein, via a CRISPR/Cas9 library screen, the effects of ferroptosis agonists were increased in KRAS-mutant PC cells upon knockout of tropomodulin 3 (TMOD3), while these effects were not
Zhirui Zeng
exaly +3 more sources
Tropomyosin-binding properties modulate competition between tropomodulin isoforms
The formation and fine-tuning of cytoskeleton in cells are governed by proteins that influence actin filament dynamics. Tropomodulin (Tmod) regulates the length of actin filaments by capping the pointed ends in a tropomyosin (TM)-dependent manner. Tmod1,
Natalia Moroz +2 more
exaly +2 more sources
MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3
Carcinogenesis, 2022Zhiyuan Chen, Hang Li, Guoxing Feng
exaly
Tropomodulin�3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway
Oncology Reports, 2019Zhikang Chen
exaly
Functional effects of mutations in the tropomyosin‐binding sites of tropomodulin1 and tropomodulin3
Cytoskeleton, 2014Velia Fowler
exaly

